TABLE 1.
Clinical characteristics of SCD patients with and without vasculopathy
| Total SCD patients | SCD patients with no vasculopathy | SCD patients with vasculopathy | p‐value | |
|---|---|---|---|---|
| n (%) | 50 | 34 (68) | 16 (32) | ‐ |
| Age a (year) | 28 (22–39) | 27.5 (21–33) | 37.5 (26. 5–41) | .039 |
| Sex F/M | 35/15 | 24/10 | 10/6 | .514 |
| SCD genotype | .48 | |||
| SS patients n, (%) | 25 (50) | 18 (52.9) | 7 (43.8) | ‐ |
| Sβ patients n, (%) | 17 (34) | 12 (35) | 5 (31) | ‐ |
| SC patients n, (%) | 8 (16) | 4 (11.8) | 4 (25) | ‐ |
| Hydroxyurea n, (%) | 10 (20) | 7 (20.5) | 3 (18.75) | 1.0 |
| Thromboembolic complications n, (%) | 13 (26) | 9 (26) | 4 (25) | .746 |
Note: Bold values indicate the statistically significant with p‐value < 0.05 (p < .05).
Abbreviation: SCD, sickle cell disease.
a
Data are shown as medians and corresponding interquartile ranges.